Home Biosimilar Antibodies Protein Tyrosine Kinase c-Met Rilotumumab (Anti-HGF / SF) For research use only.
Not for use in humans.

Rilotumumab (Anti-HGF / SF)

Synonyms: AMG 102

Rilotumumab (Anti-HGF / SF) is a monoclonal antibody that inhibits HGF/MET-driven signaling. Rilotumumab shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid tumor research. MW: 145.5 KD.

Rilotumumab (Anti-HGF / SF)

Purity & Quality Control

Batch: A246901 Purity: 99% Protein concentration: 14.86mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective c-Met Inhibitors

Biological Activity

Description Rilotumumab (Anti-HGF / SF) is a monoclonal antibody that inhibits HGF/MET-driven signaling. Rilotumumab shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid tumor research. MW: 145.5 KD.

Product Details

CAS No. 872514-65-3
Molecular Weight 145.5 kDa
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Rilotumumab (Anti-HGF / SF) | Rilotumumab (Anti-HGF / SF) supplier | purchase Rilotumumab (Anti-HGF / SF) | Rilotumumab (Anti-HGF / SF) cost | Rilotumumab (Anti-HGF / SF) manufacturer | order Rilotumumab (Anti-HGF / SF) | Rilotumumab (Anti-HGF / SF) distributor